The trademark application UATAU was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on January 26, 2017, and it was registered by office on May 7, 2017 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Change of name and professional address of the trademark registration was recorded on December 19, 2018. Appointment and Replacement of representative of the trademark registration was recorded on April 4, 2019.
Goods And Services
The mark was filed in class 5 with following description of goods:
Diagnostic agents, preparations and substances for medical purposes
Diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use
In vivo diagnostic agents used for scanning, detection and monitoring of proteins in the brain
Radiopharmaceutical diagnostic preparations for medical use
Radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases